HistoSonics
Signal active
Organization
Contact Information
Overview
HistoSonics provides the Edison Platform, which uses advanced imaging and proprietary sensing technology to deliver non-invasive, personalized treatments with precision and control, and uses the science of histotripsy and focused sound energy to generate pressures to liquify and completely destroy targeted tissues at sub-cellular levels.
About
Industries
Health Care, Medical, Medical Device
Founded
2009
Employees
51-100
Headquarters locations
United States, North America
Social
N/A
Profile Resume
HistoSonics headquartered in United States, North America, operates in the Health Care, Medical, Medical Device sector. The company focuses on Health Care and has secured $27.2B in funding across 120 round(s). With a team of 51-100 employees, HistoSonics is actively contributing to advancements in Health Care. Their latest funding round, Series A - HistoSonics, raised $14.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
11
Investors
5
Lead Investors
0
Total Funding Amount
$226.8M
Details
5
HistoSonics has raised a total of $226.8M in funding over 5 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2020 | Late Stage Venture | 40.0M | ||
| 2017 | Early Stage Venture | 8.3M | ||
| 2014 | Early Stage Venture | |||
| 2010 | Early Stage Venture | 14.0M |
Investors
HistoSonics is funded by 53 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Hatteras Venture Partners | - | FUNDING ROUND - Hatteras Venture Partners | 14.0M |
| TGap Ventures | - | FUNDING ROUND - TGap Ventures | 14.0M |
| HistoSonics | - | FUNDING ROUND - HistoSonics | 14.0M |
| Early Stage Partners | - | FUNDING ROUND - Early Stage Partners | 14.0M |
Recent Activity
There is no recent news or activity for this profile.